PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
1 hedge funds and large institutions have $1.93M invested in PRA Health Sciences, Inc. in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 313 closing their positions.
100% less funds holding
Funds holding: 317 → 1 (-316)
100% less capital invested
Capital invested by funds: $9.92B → $1.93M (-$9.92B)
100% less funds holding in top 10
Funds holding in top 10: 20 → 0 (-20)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 313
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$720M |
| 2 |
Millennium Management
New York
|
-$616M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$536M |
| 4 |
HI
HBK Investments
Dallas,
Texas
|
-$525M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$380M |
PRAH Hedge Fund Activity: Q3 2021 in Review
1 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q3 2021, worth a combined $1.93M — down 100% from $9.92B a quarter earlier.
Sellers outnumbered buyers: 313 funds closed out of PRAH and 0 opened new positions — a net loss of 313 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $720M sold.
- 1 institutional investor held PRA Health Sciences, Inc. (PRAH) as of Q3 2021, down from 317 in Q2 2021.
- Funds reported $1.93M of PRA Health Sciences, Inc. stock for Q3 2021, down 100% quarter-over-quarter.
- 0 funds opened new PRA Health Sciences, Inc. positions in Q3 2021 and 313 closed out, a net change of -313 holders.
- The largest PRA Health Sciences, Inc. seller in Q3 2021 was BlackRock, an estimated $720M sold.
Based on aggregated 13F filings for Q3 2021.